These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6202231

  • 1. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
    Sato S, Quarles RH, Brady RO, Tourtellotte WW.
    Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cleavage of myelin basic protein by acid-soluble neutral proteases of delipidated white matter.
    Berlet HH, Ilzenhöfer H, Meyer A.
    Prog Clin Biol Res; 1984 Mar; 146():243-8. PubMed ID: 6201895
    [No Abstract] [Full Text] [Related]

  • 4. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
    Möller JR, Yanagisawa K, Brady RO, Tourtellotte WW, Quarles RH.
    Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
    [Abstract] [Full Text] [Related]

  • 5. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE, Pezeshkpour GH, Pressman NJ, Wolinsky JS, Quarles RH, Dobersen MJ, Trapp BD, Kitt CA, Aksamit A, Johnson RT.
    Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
    Banik NL.
    Crit Rev Neurobiol; 1992 Sep; 6(4):257-71. PubMed ID: 1384994
    [Abstract] [Full Text] [Related]

  • 7. Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.
    Sato S, Yanagisawa K, Miyatake T.
    Neurochem Res; 1984 May; 9(5):629-35. PubMed ID: 6206410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cleavage of myelin basic protein by neutral protease activity of human white matter and myelin.
    Berlet HH, Ilzenhöfer H, Schulz G.
    J Neurochem; 1984 Sep; 43(3):627-33. PubMed ID: 6205122
    [Abstract] [Full Text] [Related]

  • 10. Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin.
    Kerlero de Rosbo N, Carnegie PR, Bernard CC.
    J Neurochem; 1986 Oct; 47(4):1007-12. PubMed ID: 2427652
    [Abstract] [Full Text] [Related]

  • 11. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG, Moscarello MA.
    J Neurosci Res; 2005 May 01; 80(3):301-8. PubMed ID: 15704220
    [Abstract] [Full Text] [Related]

  • 12. Determination of the sequential degradation of myelin proteins by macrophages.
    van der Goes A, Boorsma W, Hoekstra K, Montagne L, de Groot CJ, Dijkstra CD.
    J Neuroimmunol; 2005 Apr 01; 161(1-2):12-20. PubMed ID: 15748939
    [Abstract] [Full Text] [Related]

  • 13. Enzymatic degradation of myelin basic protein in central nervous system lesions of monkeys with experimental allergic encephalomyelitis.
    Rauch HC, Einstein ER, Csejtey J.
    Neurobiology; 1973 Apr 01; 3(3):195-205. PubMed ID: 4124846
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.
    Sato S, Quarles RH, Brady RO.
    J Neurochem; 1982 Jul 01; 39(1):97-105. PubMed ID: 6177834
    [No Abstract] [Full Text] [Related]

  • 15. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.
    Cuzner ML, Davison AN, Rudge P.
    Ann Neurol; 1978 Oct 01; 4(4):337-44. PubMed ID: 83119
    [Abstract] [Full Text] [Related]

  • 16. [A new highly active proteolytic myelin enzyme and its possible role in the mechanism of the demyelinating process].
    Savchenko IuN, Zavalishin IA, Zakharova MN, Khrustaleva NA, Khokhlov AP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989 Oct 01; 89(1):49-53. PubMed ID: 2718665
    [Abstract] [Full Text] [Related]

  • 17. Determination of a native proteolytic site in myelin-associated glycoprotein.
    Stebbins JW, Jaffe H, Fales HM, Möller JR.
    Biochemistry; 1997 Feb 25; 36(8):2221-6. PubMed ID: 9047323
    [Abstract] [Full Text] [Related]

  • 18. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA, Harauz G.
    Int Rev Neurobiol; 2007 Feb 25; 79():149-72. PubMed ID: 17531841
    [Abstract] [Full Text] [Related]

  • 19. [Isolation and various properties of leucine aminopeptidase from biological fluids of patients with multiple sclerosis].
    Khokhlov AP, Baskaeva TS, Khrustaleva NA, Zavalishin IA, Mozzhechkov VT.
    Vopr Med Khim; 1987 Feb 25; 33(2):58-62. PubMed ID: 3604142
    [Abstract] [Full Text] [Related]

  • 20. Effects of trypsin and plasmin treatment of myelin on the myelin-associated glycoprotein and basic protein.
    Inuzuka T, Sato S, McIntyre LJ, Quarles RH.
    J Neurochem; 1984 Aug 25; 43(2):582-5. PubMed ID: 6204016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.